Biotricity, Inc.
BTCY
$0.48
-$0.02-4.02%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 63.03% | 62.45% | 40.25% | 26.85% | 24.83% |
| Total Depreciation and Amortization | 12.40% | 65.04% | 65.04% | 64.65% | 64.65% |
| Total Amortization of Deferred Charges | -67.61% | -65.63% | -10.73% | 9.43% | 39.40% |
| Total Other Non-Cash Items | 16.56% | -6.66% | 115.30% | -28.13% | 16.90% |
| Change in Net Operating Assets | -73.02% | -72.73% | -73.87% | 9.88% | -7.67% |
| Cash from Operations | 89.76% | 80.19% | 64.44% | 57.53% | 52.98% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 15.48% | -8.21% | -51.91% | -55.02% | -74.34% |
| Total Debt Repaid | -7.40% | -110.89% | -- | -2,399.84% | -- |
| Issuance of Common Stock | -100.00% | -100.00% | 4.95% | 4.95% | 4.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -89.85% | -38.67% | 39.87% | 39.87% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 0.00% | -67.60% | 0.00% | 89.95% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -84.41% | -76.17% | -71.38% | -48.88% | -57.76% |
| Foreign Exchange rate Adjustments | 346.85% | -57.38% | -82.12% | -80.96% | -87.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.16% | 487.85% | -295.18% | 215.89% | 20.93% |